Eli Lilly's Stock May Fall Further

The drug company warned that its 2014 revenue target may not be met. Moreover, the valuation on Eli Lilly's stock looks rich.

As Eli Lilly & Co. met today with analysts and investors at its Indianapolis headquarters, the U.S. drug giant claimed it had created the strongest pipeline of experimental drugs in its 137-year history.